Fevipiprant, a Selective Prostaglandin-D2 Receptor-2 Antagonist, Inhibits Human Group-2 Innate Lymphoid Cell Aggregation and Function
Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2019.02.015
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2019
Authors
Publisher
Elsevier BV